20: Best abstract: Azathioprine dose reduction in Inflammatory Bowel Disease patients on combination therapy: A prospective studyECCO'16 Amsterdam
2016
1
21: Best abstract: Comparison of adalimumab monotherapy and a combination with azathioprine for patients with Crohn’s Disease: A prospective, multicentre, open-labeled clinical trial (DIAMOND study)ECCO'16 Amsterdam
2016
1
23: Best abstract: Risk factors for colorectal neoplasia in Ulcerative Colitis: Results from the largest and longest-running colonoscopic surveillance programmeECCO'16 Amsterdam
2016
1
23: Where is the unmet need for patients with IBD?3rd Basic ECCO: EduCational COurse for Industry
2016
1
24: Best abstract: Evolution of corticosteroid use in Crohn’s Disease patients between 1991 and 2014: Results from the Dutch population-based IBDSL cohortECCO'16 Amsterdam
2016
1
27: Best abstract: A multicentre, double-blind, placebo-controlled phase3 study of ustekinumab, a human interleukins-12/23p40 mab, in moderate-severe Crohn’s Disease refracto-ry to anti-TNFα: UNITI-1ECCO'16 Amsterdam
2016
1